In 2024, the Tbilisi Free Zone (TFZ) once again confirmed its importance for international businesses. A new player, CIS Farma LLC, a subsidiary of Welfar Central İlaç A.Ş., began operations in the zone, offering top-quality pharmaceutical services to its customers.
CIS Farma LLC: High Standards and Global Quality
CIS Farma LLC is an international pharmaceutical company and a subsidiary of Welfar Central İlaç A.Ş., headquartered in Istanbul, Turkey. With over 25 years of experience in patient care, company maintains a strong presence across nine CIS countries, including Georgia.
CIS Farma LLC’s core activities include:
- Pharmaceutical Warehousing: Using modern infrastructure, the company ensures secure and compliant storage of medications.
- Repackaging: Products are repackaged according to international standards, ensuring safety and quality.
Import and Export: The company imports pharmaceutical products and re-exports them across the CIS region, increasing accessibility in the area.
Why TFZ?
CIS Farma LLC’s decision to operate in the Tbilisi Free Zone was based on several key factors:
- Tax Benefits: Businesses registered in TFZ are permanently exempt from all corporate taxes, reducing operational costs and increasing competitiveness.
- Geographic Advantage: Georgia’s strategic location between Europe and Asia enables more efficient logistics and supply chain management.
- Infrastructure Support: TFZ provides pharmaceutical-grade warehousing and production facilities that meet global standards.
- Business Environment: The zone offers rapid startup and development conditions, ideal for international companies.
Impact on Georgia’s Economy and Local Population
CIS Farma LLC’s presence in TFZ positively influences both the national economy and the local community:
Economic Advantages:
- Employment: Dozens of locals are employed, receiving skills development that supports the region’s socio-economic growth.
- Export-Oriented Production: Product exports improve Georgia’s trade balance and strengthen its regional economic role.
- Investment in Innovation: The company invests in new technologies, enhancing product quality and market competitiveness.
International Partnerships and Future Perspectives
CIS Farma LLC-operations are guided by a strategic vision and strong collaboration with its parent company. With expansion plans underway—including new product lines and service upgrades—CIS Farma LLC is well-positioned for continued growth.
CIS Farma LLC’s entry into the Tbilisi Free Zone highlights Georgia’s growing role as a hub for international business and innovation. Beyond economic benefit, the company introduces advanced technologies and best practices to the local pharmaceutical sector, improving both industry standards and public health.
